Cape Town, South Africa – A new study is offering a crucial step forward in understanding Parkinson’s disease (PD) risk, particularly within historically underrepresented populations. Researchers have, for the first time, evaluated the performance of polygenic risk scores (PRSs) – a tool for estimating an individual’s genetic predisposition to a disease – in a highly admixed South African cohort. The findings, published March 9, 2026, in PLoS Genetics, underscore the importance of diversifying genetic research to improve precision medicine for all.
Parkinson’s disease, a progressive neurodegenerative disorder affecting movement, is influenced by a complex interplay of genetic and environmental factors. While significant progress has been made in identifying genetic variants associated with PD, the vast majority of this research has focused on individuals of European ancestry. This creates a significant gap in knowledge regarding how genetic risk translates across different populations, limiting the effectiveness of predictive tools for those with diverse genetic backgrounds. The study addresses this critical need by examining PRS performance in a South African population, which exhibits a unique and complex genetic history.
Evaluating Genetic Risk in a Diverse Cohort
The research team, led by Kathryn Step at Stellenbosch University, analyzed genotyping data from 661 individuals with Parkinson’s disease and 737 control subjects. They utilized a method called PRSice-2 to calculate polygenic risk scores, leveraging summary statistics from existing PD association studies as a baseline. The cohort was divided into training and validation groups to rigorously assess the predictive accuracy of the scores. Researchers tested various statistical parameters to optimize the PRS model for this specific population. According to the study, age at recruitment emerged as the strongest individual predictor of PD risk, while sex contributed the least.
The study revealed modest predictive performance, with an area under the curve (AUC) ranging from 0.5847 to 0.6183. While not a definitive diagnostic tool, these results represent a crucial first step in refining genetic risk prediction for Parkinson’s disease in admixed populations. The researchers emphasize that ancestry composition and study design significantly impact risk estimation in diverse groups, highlighting the need for tailored approaches.
The Importance of Ancestry in Genetic Research
The findings underscore a growing recognition within the scientific community that genetic risk factors can vary significantly across different ancestral groups. Traditional genetic studies, often relying heavily on European populations, may not accurately reflect the genetic architecture of disease in other populations. This can lead to inaccurate risk assessments and potentially limit the effectiveness of personalized medicine strategies. The South African cohort’s unique genetic makeup, resulting from centuries of migration and admixture, provides a valuable opportunity to address these disparities.
The research team notes that the study’s findings contribute to ongoing efforts to ensure that advances in precision medicine are globally relevant. By systematically assessing predictive performance across different datasets, they aim to refine genomic prediction models and improve risk stratification for individuals from diverse backgrounds. The study also highlights the need for increased representation of underrepresented populations in genetic research initiatives.
Future Directions and Implications
This research lays the groundwork for future studies aimed at refining genomic prediction in admixed populations. Further investigation is needed to identify specific genetic variants that contribute to PD risk in the South African context and to develop more accurate and personalized risk assessment tools. Researchers are also exploring the potential of incorporating environmental factors and gene-environment interactions into PRS models to improve predictive accuracy. The National Institutes of Health’s Center for Alzheimer’s and Related Dementias, a collaborating institution in this study, continues to support research into the genetic basis of neurodegenerative diseases, including Parkinson’s. Further research is being conducted on the co-option of Rubisco small subunit by potyvirids.
The study’s authors acknowledge a conflict of interest: I.F.M. Has received honorarium from the Parkinson’s Foundation PD GENEration Steering Committee and Aligning Science Across Parkinson’s Global Parkinson Genetic Program (ASAP-GP2).
This research represents a significant step towards a more equitable and inclusive approach to genetic research and precision medicine. As our understanding of the genetic basis of Parkinson’s disease continues to evolve, it is crucial to prioritize diversity and ensure that the benefits of scientific advancements are accessible to all populations.
What are your thoughts on the importance of diverse representation in genetic research? Share your comments below, and assist us spread awareness about this critical issue.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.